The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group

Published:2019-08 Issue:4 Volume:43 Page:344-353
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

Araz Murat^ORCID,Karaagac Mustafa,Korkmaz Levent,Beypinar Ismail,Uysal Mukremin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference13 articles.

1. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients;Roila;Ann Oncol,2016

2. The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue;Carlotto;Pharmaco Econ,2013

3. International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice;Jordan;Eur J Pharmacol,2014

4. Obstacles to the implementation of antiemetic guidelines;Grunberg;JNCCN J Natl Comprehensive Cancer Network,2009

5. The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER);Aapro;Ann Oncol,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in chemotherapy induced nausea and vomiting (CINV) management: A systematic review;Tropical Journal of Pharmaceutical Research;2024-04-14

2. Retrospective analysis of real‐world prescribing data for managing cisplatin‐based chemotherapy‐induced nausea and vomiting in China;Cancer Medicine;2024-03

3. 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential;Supportive Care in Cancer;2023-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3